XML 24 R21.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCK-BASED COMPENSATION
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION
All stock-based awards are subject to the terms of the 2009 Performance Incentive Plan, which was assumed by the Company effective as of November 15, 2010 in connection with the Company’s separation from Sun and was most recently amended and restated in April 2017. The 2009 Performance Incentive Plan provides for the granting of stock-based compensation, including stock options, time-based stock units, funds from operations-based stock units (“FFO Units”), relative total stockholder return-based stock units (“TSR Units”) and performance-based restricted stock units to officers, employees and directors in connection with their employment with or services provided to the Company.
Stock Options
In connection with the CCP Merger, the Company assumed stock options outstanding as of the effective time of the CCP Merger.
During the year ended December 31, 2019, no stock options were exercised and 1.2 million stock options expired. As of December 31, 2019, no stock options were outstanding.
As of December 31, 2018, 1.2 million stock options with a weighted average exercise price per share of $28.04 were outstanding.
Restricted Stock Units and Performance-Based Restricted Stock Units
Under the 2009 Performance Incentive Plan, restricted stock units and performance-based restricted stock units generally have a contractual life or vest over a three- to five-year period. The vesting of certain restricted stock units may accelerate, as defined in the grant, upon retirement, a change in control and other events. When vested (and subject to any applicable deferral or holdback period), each performance-based restricted stock unit is convertible into one share of common stock, subject to any deferrals in issuance pursuant to the grant. The restricted stock units are valued on the grant date based on the market price of the Company’s common stock on that date. Generally, the Company recognizes the fair value of the awards over the applicable vesting period as compensation expense. In addition, since the shares to be issued may vary based on the performance of the Company, the Company must make assumptions regarding the projected performance criteria and the shares that will ultimately be issued. The amount of FFO Units that will ultimately vest is dependent on the amount by which the Company’s funds from operations as adjusted (“FFO”) differs from a target FFO amount for a period specified in each grant and will range from 0% to 200% of the FFO Units initially granted. Similarly, the amount of TSR Units that will ultimately vest is dependent on the amount by which the total shareholder return (“TSR”) of the Company’s common stock differs from a predefined peer group for a period specified in each grant and will range from 0% to 200% of the TSR Units initially granted. Upon any payment of shares as a result of restricted stock unit vestings, the related tax withholding obligation will generally be satisfied by the Company, reducing the number of shares to be delivered by a number of shares necessary to satisfy the related applicable tax withholding obligation. The value of the shares withheld is dependent on the closing price of the Company’s common stock on the date the relevant transaction occurs.
The following table summarizes additional information concerning restricted stock units at December 31, 2019:
 
 
Restricted Stock Units
 
Weighted Average Grant Date Fair Value Per Unit
Unvested as of December 31, 2018
 
1,477,318

 
$
17.88

Granted
 
603,131

 
20.59

Vested
 
(433,181
)
 
18.34

Dividends reinvested
 
152,329

 
18.60

Cancelled/forfeited
 
(61,735
)
 
18.29

Unvested as of December 31, 2019
 
1,737,862

 
$
18.90


As of December 31, 2019, the weighted average remaining vesting period of restricted stock units was 2.5 years. The weighted average fair value per share at the date of grant for restricted stock units for the years ended December 31, 2019, 2018 and 2017 was $20.59, $16.02 and $19.38, respectively. The total fair value of units vested during the years ended December 31, 2019, 2018 and 2017 was $7.9 million, $3.6 million and $8.4 million, respectively.
The fair value of the TSR Units is estimated on the date of grant using a Monte Carlo valuation model that uses the assumptions noted in the table below. The risk-free rate is based on the U.S. Treasury yield curve in effect at the grant date for the expected performance period. Expected volatility is based on historical volatility for the most recent 3-year period ending on the grant date for the Company and the selected peer companies, and is calculated on a daily basis. The following are the key assumptions used in this valuation:
 
2019
 
2018
 
2017
Risk free interest rate
1.57% - 2.54%

 
2.36% - 2.59%

 
1.42% - 1.99%

Expected stock price volatility
23.80% - 28.57%

 
28.57% - 30.02%

 
28.86% - 30.97%

Expected service period
2.4 - 3.0 years

 
2.5 - 3.0 years

 
2.2 - 3.0 years

Expected dividend yield (assuming full reinvestment)
%
 
%
 
%

During the years ended December 31, 2019, 2018 and 2017, the Company recognized $9.8 million, $7.6 million and $7.0 million, respectively, of stock-based compensation expense included in general and administrative expense in the consolidated statements of income. During the year ended December 31, 2017, the Company recognized $1.4 million of stock-based compensation expense related to former CCP employees included in merger and acquisition costs in the consolidated statements of income. As of December 31, 2019, there was $20.1 million of total unrecognized stock-based compensation expense related to unvested awards, which is expected to be recognized over a weighted average period of 2.5 years.
Employee Benefit Plan
The Company maintains a 401(k) plan that allows for eligible participants to defer compensation, subject to certain limitations imposed by the Internal Revenue Code of 1986, as amended (the “Code”). The Company provides a discretionary matching contribution of up to 3% of each participant’s eligible compensation. During the years ended December 31, 2019, 2018 and 2017, the Company’s matching contributions were approximately $211,000, $171,000 and $143,000, respectively.